Company News & Publications

Upcoming Conferences

BIO-Europe 2015
Munich, Germany

» Visit website

nov, 2015



ICAB 2015
Budapest, Hungary

» Visit website

NOV, 2015

Latest events

BIO International Convention
Philadelphia, PA, USA

» Visit website

june, 2015

Formulation & Drug Delivery Congress

London, UK

» Visit website

May, 20115


6th Annual Global Drug Delivery & Formulation Summit
Düsseldorf, Germany
» Visit website

FEB, 2015


BIO Europe
Frankfurt, Germany
» Visit website

Nov, 2014


Jun, 2014

Bio International Conveniton
San Diego, CA, USA
» Visit website

May, 2014

Lodz, Poland
» Visit website

May, 2014

2nd Annual Formulation and Drug Delivery
Boston, MA, USA
» Visit website

May, 2014

4th International Workshop on A to Z Bioequivalence Bioanalysis, Dissolution and Biosimilarity
Budapest, Hungary
» Visit website

PBP World Meeting
Lisbon, Portugal
» Visit website

Mar, 2014

World Drug Delivery and Formulation 2014
Berlin, Germany
» Visit website

Feb, 2014

JP Morgan 32nd Annual Healthcare Conference
San Francisco, CA, USA
» Visit website

Jan, 2014


News & Press releases

Quotient Clinical begins prostate cancer project for Druggability Technologies

June 23, 2015 - Quotient Clinical, the Translational Pharmaceutics® Company, initiates a new RapidFACT program for Druggability Technologies (DRGT) for evaluating enhanced formulations of abiratone acetate.

» Read more

Gabor Heltovics, CEO to present at Formulation & Drug Delivery Congress, London, UK.

Join our sesseion on Day 1 , Optimising Formulation steam, 12.20 -  12.50 pm. and learn more on our latest achievments.



Druggability Technologies enters into a strategic collaboration with Bayer HealthCare

DRGT signs a broad collaboration agreement with Bayer HealthCare to leverage DRGT’s Super-API Technology to accelerate the discovery and development of novel drugs.

» Read more

Druggability Technologies Announces Financial Investment by SPCH

Druggability Technologies Holdings Limited (DRGT), a privately held biotechnology platform company, announced today that it has completed an initial round of financing totaling $4,000,000.

» Read more


Sirolimus formulation with improved pharmacokinetic properties produced by a continuous flow method

Tamás Solymosi, Réka Angi, Orsolya Basa-Dénes, Soma Ránky , Zsolt Ötvös, Hristos Glavinas, Genovéva Filipcsei  and Gábor Heltovics

» Read publication


Novel Continuous flow technology for the development of nanostructured Aprepitant formulation with improved pharmacocinetics properties

Réka Angi, Tamás Solymosi, Zsolt Ötvös, Betti Ordasi, Hristos Glavinas, Genovéva Filipcsei, Gábor Heltovics and Ferenc Darvas

» Read publication


Flow chemistry for nanotechnology, Flow chemistry graduate textbook, Chapter 6, Vol.2.: Applications,  Ed. by Darvas, Ferenc / Hessel, Volker / Dorman, György, Walter de Gruyter, 2014, pp 161-187

Genovéva Filipcsei, Zsolt Ötvös, Réka Angi and Ferenc Darvas

» Read publication